1. A Simple Preparation Method of Gelatin Hydrogels Incorporating Cisplatin for Sustained Release
- Author
-
Takahisa Suzuki, Shigeru Tsunoda, Kota Yamashita, Toshie Kuwahara, Mitsuru Ando, Yasuhiko Tabata, and Kazutaka Obama
- Subjects
gelatin hydrogel ,sustained release ,crosslinking method ,cisplatin ,gastric cancer ,peritoneal metastases ,Pharmacy and materia medica ,RS1-441 - Abstract
The objective of this study was to develop a new preparation method for cisplatin (CDDP)-incorporated gelatin hydrogels without using chemical crosslinking nor a vacuum heating instrument for dehydrothermal crosslinking. By simply mixing CDDP and gelatin, CDDP-crosslinked gelatin hydrogels (CCGH) were prepared. CDDP functions as a crosslinking agent of gelatin to form the gelatin hydrogel. Simultaneously, CDDP is incorporated into the gelatin hydrogel as a controlled release carrier. CDDP’s in vitro and in vivo anticancer efficacy after incorporation into CCGH was evaluated. In the in vitro system, the CDDP was released gradually due to CCGH degradation with an initial burst release of approximately 16%. CDDP metal-coordinated with the degraded fragment of gelatin was released from CCGH with maintaining the anticancer activity. After intraperitoneal administration of CCGH, CDDP was detected in the blood circulation while its toxicity was low. Following intraperitoneal administration of CCGH in a murine peritoneal dissemination model of human gastric cancer MKN45-Luc cell line, the survival time was significantly prolonged compared with free CDDP solution. It is concluded that CCGH prepared by the CDDP-based crosslinking of gelatin is an excellent sustained release system of CDDP to achieve superior anticancer effects with minimal side effects compared with free CDDP solution.
- Published
- 2022
- Full Text
- View/download PDF